Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Packer

Showing results (281-290 of 4,797) with videos related to

Pageof 480
Sort By:
Drug Metabolism Reviews|June 2, 1998
alpha-Lipoic acid: a metabolic antioxidant which regulates NF-kappa B signal transduction and protects against oxidative injuryL Packer
Chest|June 1, 1989
Is it ethical to administer vasodilator drugs to patients with primary pulmonary hypertension?M Packer
The Western Journal of Medicine|July 1, 1990
Due processM Packer
Cardiology|January 1, 1989
Identification of risk factors predisposing to the development of functional renal insufficiency during treatment with converting-enzyme inhibitors in chronic heart failureM Packer
Circulation|December 1, 1989
Pathophysiological mechanisms underlying the adverse effects of calcium channel-blocking drugs in patients with chronic heart failureM Packer
The American Journal of Medicine|November 7, 2017
Early Worsening of Renal Function After Treatment with Antihyperglycemic Drugs: A Consistent Finding in Large-Scale TrialsMilton Packer
European Journal of Heart Failure|August 12, 2016
Kicking the tyres of a heart failure trial: physician response to the approval of sacubitril/valsartan in the USAMilton Packer
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 4, 2020
Do amiodarone and dronedarone prevent thrombo-embolic stroke by treating the atrial myopathy of patients with atrial fibrillation? A provocative hypothesisMilton Packer
Circulation. Heart Failure|June 15, 2021
Pitfalls in Using Estimated Glomerular Filtration Rate Slope as a Surrogate for the Effect of Drugs on the Risk of Serious Adverse Renal Outcomes in Clinical Trials of Patients With Heart FailureMilton Packer
Clinical Ophthalmology (Auckland, N.Z.)|June 1, 2022
Evaluation of the EVO/EVO+ Sphere and Toric Visian ICL: Six Month Results from the United States Food and Drug Administration Clinical TrialMark Packer
Pageof 480

Showing results (281-290 of 4,797) with videos related to

Sort By:
Pageof 480
Drug Metabolism Reviews|June 2, 1998
alpha-Lipoic acid: a metabolic antioxidant which regulates NF-kappa B signal transduction and protects against oxidative injuryL Packer
Chest|June 1, 1989
Is it ethical to administer vasodilator drugs to patients with primary pulmonary hypertension?M Packer
The Western Journal of Medicine|July 1, 1990
Due processM Packer
Cardiology|January 1, 1989
Identification of risk factors predisposing to the development of functional renal insufficiency during treatment with converting-enzyme inhibitors in chronic heart failureM Packer
Circulation|December 1, 1989
Pathophysiological mechanisms underlying the adverse effects of calcium channel-blocking drugs in patients with chronic heart failureM Packer
The American Journal of Medicine|November 7, 2017
Early Worsening of Renal Function After Treatment with Antihyperglycemic Drugs: A Consistent Finding in Large-Scale TrialsMilton Packer
European Journal of Heart Failure|August 12, 2016
Kicking the tyres of a heart failure trial: physician response to the approval of sacubitril/valsartan in the USAMilton Packer
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 4, 2020
Do amiodarone and dronedarone prevent thrombo-embolic stroke by treating the atrial myopathy of patients with atrial fibrillation? A provocative hypothesisMilton Packer
Circulation. Heart Failure|June 15, 2021
Pitfalls in Using Estimated Glomerular Filtration Rate Slope as a Surrogate for the Effect of Drugs on the Risk of Serious Adverse Renal Outcomes in Clinical Trials of Patients With Heart FailureMilton Packer
Clinical Ophthalmology (Auckland, N.Z.)|June 1, 2022
Evaluation of the EVO/EVO+ Sphere and Toric Visian ICL: Six Month Results from the United States Food and Drug Administration Clinical TrialMark Packer
Pageof 480